Research and Development

The new head of US regulator the FDA has set out a vision to support public health, through tighter laws …

The UK pharmaceutical sector is set to get its own body dedicated to identifying and addressing key skills issues. A …

Pharmafocus presents its periodic round-up of developments in the contract research sector, including updates from Pharm-Olam, OmniComm, SIRO, Ecron Acunova …

Contract preclinical testing specialist Charles River Laboratories saw its second-quarter sales drop 12.5% to $308 million as demand from pharmaceutical …

Sanofi Pasteur has filed with US regulators a supplemental license application for its vaccine to protect against the H1N1 pandemic …

The new fast-tracking system announced to help accelerate uptake of innovative new treatments in the UK, could be held back …

The FDA has ruled that TNF blocker drugs should carry new warnings of the increased risk of certain cancers for …

Vernalis and GlaxoSmithKline have joined forces to work on a cancer treatment in a deal which could be worth more …

Former US President Bill Clinton has brokered major new deals with Pfizer and Mylan to cut the price of tuberculosis …

Quintiles has opened a new office in Accra, Ghana, which it says will increase capacity to manage clinical studies for …

Vaccine companies are working round the clock to develop and manufacture a vaccine for the H1N1 pandemic flu, and are …

Animal rights activists are believed to be behind two attacks on Novartis chief executive Daniel Vasella. The first attack came …

Novartis’ new kidney cancer drug Afinitor (everolimus) has been approved in the EU for use when products such as Sutent …

Adult type II diabetes treatment Onglyza has been approved by the US Food and Drug Administration. Co-marketed by AstraZeneca and …

1: The Office of Life Science’s ‘Blueprint’The first to be launched was the ‘Blueprint’ – a new strategic vision aiming …